Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

neral and

administrative 77,243 (14,393)(b)( c )(d) 62,850

Total operating expenses 266,773 (184,928) 81,845

Operating income (loss) (156,475) 198,866 42,391

Interest and other income

(expense), net (26,898) (26,898)

Income tax (benefit)

provision (1,645) 3,449(g) 1,804

Equity earnings of

unconsolidated entities,

net of tax 1,116 112(b) 1,228

Net (loss) income $(180,612) $195,529 $14,917

Preferred stock dividends $- $-

Net (loss) income

available to common

stockholders - basic $(180,612) $14,917

Net (loss) income per

common share

Basic $(3.74) $0.31

Diluted $(3.74)(h) $0.29(j)

Weighted average common

shares - basic 48,256 48,256

Weighted average common

shares - diluted 48,256(h) 51,483(j)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges, including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a significant positive or

negative impact on results yet do not occur on a consistent or

regular basis in its business. In determining whether a particular

item meets one of these criteria, management considers facts and

circumstances that it believes are relevant. Management believes

that
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
(Date:6/19/2013)... Adding to their already extensive supply of ... Dropette® and Heathrow Scientific disposable plastic transfer ... biology, chemistry and any type of liquid handling analysis ... years, Simport has been supplying the science community with ... Simport Dropette®. Simport’s Dropette® is a one-piece plastic ...
(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13
... be Addressed by Board and Management on Avigen,s February ... Biotechnology Value Fund, L.P. ("BVF"), today called for ... ) to address certain fundamental questions BVF believes need ... evaluate Avigen,s future strategic direction. Avigen announced in ...
... Jennerex, Inc. (San Francisco, CA,and Ottawa, Canada) a ... Reviews Cancer, has published an article about,the company,s ... encouraging clinical and preclinical data. The article,published ... David H. Kirn, M.D.,president and chief executive officer ...
... System Will Continue to Fuel Growth and Generate CashNEW YORK, ... Vice President James C. Borel said today he expects DuPont ... share by at least 1 to 2 points in 2009 ... DuPont Agriculture & Nutrition segment an average of at least ...
Cached Biology Technology:Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 2Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 3Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 4Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 5Nature Reviews Publishes Article About Jennerex's Multi-Mechanistic Cancer Therapeutic 2Nature Reviews Publishes Article About Jennerex's Multi-Mechanistic Cancer Therapeutic 3DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 2DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 3DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 4DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 5
(Date:6/19/2013)... A decade-long JDRF-funded study led by the Institute ... is providing a deeper understanding of the link ... 1 diabetes (T1D), highlighting the importance of pre-diabetes ... study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... today in The Journal of the American ...
(Date:6/19/2013)... Cornell University study offers further proof that the divergence ... million years ago was profoundly influenced by mutations to ... and off. , The study, published June 9 in ... hypothesis that regulation of genes must play an important ... humans and chimps in the proteins produced by genes. ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
Breaking Biology News(10 mins):New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2
... dinosaur skeleton found 24 years ago in Montana ... North American,dinosaurs with Asian dinosaurs. The dinosaur would have ... stood about three feet tall. The fossil,came from sediment ... on the finding was published in September,s issue of ...
... Exeter and Shimane University in Japan have proved for ... plant growth. This discovery could have implications for agriculture ... The study, which is now published online in ... which produces vitamin C, or ascorbate, in plants. Vitamin ...
... Sept. 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) ... announced that it has acquired a patent that ... portable locks. The company believes that this ... many years, consumers have been using portable locks, ...
Cached Biology News:New dinosaur species found in Montana 2Study shows vitamin C is essential for plant growth 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
... optimized for maximum packaging efficiencies of T7Select ... extracts (> 109 pfu/g with control DNA) ... containing at least 5 107 recombinant ... made from a specially designed phage that ...
... Mouse/Rat Tissue Extract Protein Array Kit is ... tissue extracts. The expression of a protein ... protein specific antibody. When the antibody binds ... a sensitive chemiluminescent or fluorescent signal created ...
... offers pre-validated SNP sequencing ... amplicons within 93 genes ... and more than 80 ... assays were developed and ...
Biology Products: